Clinuvel Pharmaceuticals Ltd Stock Today
| CLVLY Stock | USD 7.56 0.06 0.80% |
PerformanceWeakest
| Odds Of DistressLow
|
Clinuvel Pharmaceuticals is trading at 7.56 as of the 27th of October 2025; that is 0.80% increase since the beginning of the trading day. The stock's open price was 7.5. Clinuvel Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of September 2025 and ending today, the 27th of October 2025. Click here to learn more.
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. The company has 49.41 M outstanding shares. More on Clinuvel Pharmaceuticals Ltd
Moving against Clinuvel Pink Sheet
| 0.52 | CYCC | CYCC Old Symbol Change | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Clinuvel Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Clinuvel Pharmaceuticals Ltd [CLVLY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 800.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Clinuvel Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Clinuvel Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Clinuvel Pharmaceuticals classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 49.41 M outstanding shares.
Clinuvel Pharmaceuticals Ltd has accumulated about 121.51 M in cash with 39.87 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.46.
Check Clinuvel Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationClinuvel Pharmaceuticals holds a total of 49.41 Million outstanding shares. Almost 99.99 percent of Clinuvel Pharmaceuticals outstanding shares are held by general public with 0.01 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Clinuvel Ownership Details
Clinuvel Pharmaceuticals Risk Profiles
| Mean Deviation | 2.12 | |||
| Semi Deviation | 3.8 | |||
| Standard Deviation | 3.22 | |||
| Variance | 10.38 |
Clinuvel Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Clinuvel Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Clinuvel Pharmaceuticals Corporate Management
| Lachlan Hay | Director Operations | Profile | |
| Malcolm Bull | Head Relations | Profile | |
| Dennis Wright | Acting Chief Scientific Officer | Profile | |
| MBA MD | MD CEO | Profile |
Additional Tools for Clinuvel Pink Sheet Analysis
When running Clinuvel Pharmaceuticals' price analysis, check to measure Clinuvel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinuvel Pharmaceuticals is operating at the current time. Most of Clinuvel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Clinuvel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinuvel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Clinuvel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.